|
related topics |
{stock, price, share} |
{product, liability, claim} |
{control, financial, internal} |
{customer, product, revenue} |
{acquisition, growth, future} |
{stock, price, operating} |
{property, intellectual, protect} |
{competitive, industry, competition} |
{condition, economic, financial} |
{cost, operation, labor} |
|
Risk Factors Relating to Our Business
We have a history of losses and we may not be profitable in any future period.
we are unable to raise capital, our ability to implement our current business plan and ultimately our viability as a company could be adversely affected.
Our revenues have declined significantly in recent years.
Our success over the short-term depends on the commercial success of the AuraGen
products, as we are not currently engaged in any other line of business.
We may have difficulty managing our growth.
The market acceptance of the AuraGen
Our business may be adversely affected by industry competition.
We depend on our intellectual property to provide us with a competitive advantage.
We depend on third party manufacturers for certain product components.
We will need to renew sources of supply to meet increases in demand for the AuraGen
Risks Relating to Our Common Stock
Because our operating results have been uneven and may continue to fluctuate, this could affect our stock price.
We have a history of filing late periodic reports with the SEC.
We may issue additional shares of our authorized common stock without obtaining the approval of our stockholders.
Because our common stock is not traded on a national or regional market, liquidity for our common stock could be adversely impacted.
Because our common stock is subject to rules governing low priced securities, market liquidity for our common stock could be adversely impacted.
The potential exercise of outstanding warrants and options could adversely affect the market price of our common stock, dilute the holdings of existing stockholders and impede our ability to obtain additional equity financing.
We do not expect to pay dividends on our common stock in the foreseeable future.
Full 10-K form ▸
|
|
related documents |
826253--3/25/2008--AURA_SYSTEMS_INC |
724910--5/25/2007--NVE_CORP_/NEW/ |
826253--6/13/2008--AURA_SYSTEMS_INC |
1032863--4/13/2006--FORCE_PROTECTION_INC |
826253--6/15/2009--AURA_SYSTEMS_INC |
1036968--3/29/2010--VAXGEN_INC |
1036478--4/10/2008--WWA_GROUP_INC |
1413754--7/14/2009--Swav_Enterprises_Ltd. |
1378706--3/18/2008--AMERICAN_DG_ENERGY_INC |
1450552--12/29/2010--Dafoe_Corp. |
1104672--4/11/2008--MONTANA_MINING_CORP |
941685--4/15/2008--IMAGEWARE_SYSTEMS_INC |
1438672--9/7/2010--Orofino_Gold_Corp |
1160164--12/15/2010--Biomass_Secure_Power_Inc |
813747--1/4/2006--SPESCOM_SOFTWARE_INC |
919567--9/22/2006--RENAISSANCE_CAPITAL_GROWTH_&_INCOME_FUND_III_INC |
1378706--3/20/2009--AMERICAN_DG_ENERGY_INC |
1094816--7/6/2010--VOICE_MOBILITY_INTERNATIONAL_INC |
1121827--3/6/2009--BIG_SKY_INDUSTRIES_VI_INC |
1078383--3/13/2008--IPARTY_CORP |
1042610--10/13/2010--TRB_SYSTEMS_INTERNATIONAL_INC |
1014343--3/31/2008--Organic_To_Go_Food_CORP |
3116--3/30/2006--AKORN_INC |
852437--9/28/2007--AVATECH_SOLUTIONS_INC |
802257--9/28/2009--BRAIN_TREE_INTERNATIONAL_INC |
1115975--4/15/2010--SILVERGRAPH_INTERNATIONAL_INC |
1144225--4/12/2010--instaCare_Corp. |
1144225--5/18/2009--instaCare_Corp. |
1405350--4/10/2009--RxBids |
1030839--2/5/2009--Synovics_Pharmaceuticals |
|